
|Videos|November 29, 2021
CAR T and Other Emerging Therapies in R/R Multiple Myeloma: Kenneth H. Shain, MD, PhD
Author(s)Kenneth H. Shain, MD, PhD
The hematologist/oncologist at Moffitt Cancer Center discussed emerging therapies for patients with relapsed/refractory multiple myeloma.
Advertisement
This content originally appeared on our sister site,
Newsletter
Stay at the forefront of cutting-edge science with CGT—your direct line to expert insights, breakthrough data, and real-time coverage of the latest advancements in cell and gene therapy.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on CGTlive®
1
FDA Slams REGENXBIO's MPS II Gene Therapy RGX-121 With CRL
2
Ultragenyx Puts BLA for MPS IIIA Gene Therapy UX111 in Front of FDA Again
3
ImmunoLogic, Episode 8: "Surgery Meets Immunotherapy: A One-Two Punch for Breast Cancer" With Julia C. Tchou, MD, PhD, FACS
4














